2024-11-18 06:33:15
Adlai Nortye Receives NMPA Approval for Pelareorep (AN1004) in China to Initiate Phase III Clinical Trials
Health/ 2023-07-22
Adlai Nortye Receives NMPA Approval for ...

HANGZHOU,China,March 21,2019-- Adlai Nortye Ltd. ("Adlai Nortye"),a global clinical-stage biopharmaceutical company today announce...

Alvotech Enrolls First Patient in Clinical Phase III Study Involving Biosimilar Version of HUMIRA®
Health/ 2023-07-22
Alvotech Enrolls First Patient in Clinic...

Alvotech\'s AVT02 is being developed as a biosimilar of the HUMIRA® high-concentration (100mg/mL) product,expected to be more convenient...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release